Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program
暂无分享,去创建一个
L. Livi | G. Rinaldi | F. Verderame | G. Faggioni | G. Sanna | G. Bisagni | L. Coltelli | D. Grasso | V. Scotti | F. Ragni | E. Geuna | C. Arcara | G. Moretti | L. Vannini | M. Gunnellini | N. Staropoli | Giulia Abbinante | Giulia Abbinante